Globus Medical, Inc. (GMED), a musculoskeletal technology solutions company, announced financial results for the fourth quarter and fiscal year ended December 31, 2025, showing double-digit revenue growth and higher earnings compared to the prior year.
Fourth Quarter 2025 Results
Worldwide net sales were $826.4 million, up 25.7% from $657.3 million in Q4 2024.
Base business net sales were $726.7 million, compared to $657.3 million an increase of 10.6% year-over-year.
GAAP net income was $140.6 million, compared to $26.5 million in Q4 2024.
GAAP diluted EPS was $1.03, up from $0.19 in the prior-year quarter.Non-GAAP diluted EPS was $1.28, compared to $0.84 in Q4 2024, an increase of 52.1%.
Adjusted EBITDA was $280.5 million, up from $196.9 million in Q4 2024.
Fiscal Year 2025 Results
Worldwide net sales reached $2.94 billion, up 16.7% from $2.52 billion in 2024.
Base business net sales were $2.65 billion, up 5.0% from $2.52 billion year-over-year. U.S. net sales grew 18.4%, while international net sales rose 10.0%.
GAAP net income was $537.9 million, compared to $103.0 million in 2024.
GAAP diluted EPS was $3.92, up from $0.75 in 2024. Non-GAAP diluted EPS was $3.98, compared to $3.04 in 2024, an increase of 30.8%.
Free cash flow improved to $588.8 million, compared to $405.2 million in 2024.
Outlook
For fiscal year 2026, Globus Medical reaffirmed guidance:
•Revenue expected in the range of $3.18 billion to $3.22 billion, compared to $2.94 billion in 2025, representing growth of about 8-9% compared to 2025.
•Non-GAAP diluted EPS projected between $4.40 and $4.50, up from $3.98 in 2025.
GMED has traded between $29.16 and $57.65 over the past year. The stock closed Tuesday's session at $91.88, down 1.63%. In premarket trading Wednesday, the stock is up 0.84% at $92.65.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.